Research Stopping Ozempic may raise heart attack and stroke riskBy Healthcare Propulsion StaffSeptember 22, 20260 GLP-1 drugs such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) have surged in popularity for treating diabetes…